Clinical Trial Update: An Exploratory Study of the Folic Acid-tubulysin Conjugate EC1456 in Ovarian Cancer Subjects Undergoing Surgery [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 exploratory study evaluating the folic acid-tubulysin conjugate EC1456 in ovarian cancer patients undergoing sur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• EC1456 (folic acid-tubulysin conjugate)

Snippet

Sponsor: Endocyte | Conditions: Ovary Cancer | Phase 1 | Status: COMPLETED